Granulocyte-Macrophage Colony-Stimulating Factor Clinical Trials
3 recruitingDrug
Phase 22Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
Mayo Clinic43 enrolled2 locationsNCT04144023
Recruiting
Phase 2
Quadruple Immunotherapy for Neuroblastoma
Neuroblastoma Recurrent
Hong Kong Children's Hospital29 enrolled1 locationNCT05754684
Recruiting
Phase 2
Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer
Cervical Cancer
Zhongnan Hospital35 enrolled1 locationNCT05817214